New PRMRP designation creates dedicated pathway for HHT-focused research through the Department of Defense’s Congressionally Directed Medical Research Programs This is a defining moment…This federal ...

ST. LOUIS – A new, highly-specialized, multidisciplinary center focused on pediatric Hereditary Hemorrhagic Telangiectasia (HHT) has opened at SSM Health Cardinal Glennon Children’s Hospital. Dr.

A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of severe nosebleeds from a rare but devastating bleeding disorder. Hereditary ...

Patients with hereditary hemorrhagic telangiectasia (HHT), a rare genetic disorder that causes abnormal blood vessel formation, wage a lifelong battle against skin lesions, frequent nosebleeds and ...

People with HHT have a near-typical life expectancy as long as they follow their treatment plan and undergo regular screening for complications. Hereditary hemorrhagic telangiectasia (HHT) is a rare ...

MONKTON, MD, UNITED STATES, March 25, 2026 /EINPresswire.com/ — Cure HHT proudly announces the publication of “Clinical Spectrum of Hereditary Hemorrhagic ...

A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient evidence that a drug called pomalidomide, which is used to treat bone marrow ...